Resilience and Lilly Invest $750 Million to Increase U.S.-Manufactured Medicine Supply
Resilience and Lilly expand strategic partnership first established in 2023 Investment will significantly increase U.S. production of Lilly’s...
BLOG
Read on
Resilience Announces Relocation of West Coast Headquarters to Ohio and Expansion of Sterile Manufacturing Capabilities
BLUE ASH, Ohio, June 18, 2026 – Resilience, along with Ohio Governor Mike DeWine, JobsOhio, the City of Blue Ash, and REDI Cincinnati, today...
How integrated data systems enhance clinical development and manufacturing
Published by PharmaVoice In the rapidly evolving landscape of biopharmaceuticals, the integration of robust digital systems has become paramount....
.png)
CDMOs Are Making Their Supply Chains More Resilient & Secure
Published byDrug Development & Delivery Growing R&D activities, personalized medicines, large-scale production of biologics, and access to new...
Boston, MA: Process & Analytical Development and Manufacturing Facility
The launch of our Process & Analytical Development and Manufacturing Facility marks a strategic resurgence in the Boston area, as we consolidate and...
Meet the Team: Viral Vector Development & Manufacturing
Meet Kyle Anderson, Ph.D., Director of Manufacturing Science and Technology (MSAT) at Resilience RTP, North Carolina & Xiaotong Fu, Ph.D., Head of...
On-Demand Webinar: Outsourced Pharma Capacity Update 2024 - Large Molecules
Are you an innovative company looking for a dependable CDMO partner for your large molecule projects? You have come to the right place.
Scale Your Vaccine Development with Path-to-PAD
The COVID-19 pandemic highlighted the urgent need for a quick, efficient, and scalable vaccine production process. Resilience's Vaccine Path-To-PAD...
